nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—CYP2B6—Thiotepa—sarcoma	0.241	0.412	CbGbCtD
Mianserin—CYP1A2—Dacarbazine—sarcoma	0.0783	0.134	CbGbCtD
Mianserin—CYP3A4—Thiotepa—sarcoma	0.074	0.126	CbGbCtD
Mianserin—CYP2B6—Doxorubicin—sarcoma	0.0445	0.0761	CbGbCtD
Mianserin—CYP1A2—Etoposide—sarcoma	0.0383	0.0655	CbGbCtD
Mianserin—CYP3A4—Mitoxantrone—sarcoma	0.0318	0.0544	CbGbCtD
Mianserin—HTR1D—meninx—sarcoma	0.0302	0.181	CbGeAlD
Mianserin—HTR1D—dura mater—sarcoma	0.0278	0.167	CbGeAlD
Mianserin—CYP3A4—Vincristine—sarcoma	0.0219	0.0374	CbGbCtD
Mianserin—CYP2D6—Doxorubicin—sarcoma	0.0215	0.0368	CbGbCtD
Mianserin—CYP3A4—Etoposide—sarcoma	0.0201	0.0343	CbGbCtD
Mianserin—CYP3A4—Doxorubicin—sarcoma	0.0137	0.0234	CbGbCtD
Mianserin—HTR7—pulmonary artery—sarcoma	0.00944	0.0568	CbGeAlD
Mianserin—HRH4—hematopoietic system—sarcoma	0.0068	0.0409	CbGeAlD
Mianserin—HTR2A—pulmonary artery—sarcoma	0.00589	0.0354	CbGeAlD
Mianserin—HRH4—bone marrow—sarcoma	0.00436	0.0262	CbGeAlD
Mianserin—HTR2A—hindlimb—sarcoma	0.00356	0.0214	CbGeAlD
Mianserin—HTR2A—appendage—sarcoma	0.00306	0.0184	CbGeAlD
Mianserin—HTR7—endothelium—sarcoma	0.00296	0.0178	CbGeAlD
Mianserin—HRH2—hematopoietic system—sarcoma	0.00286	0.0172	CbGeAlD
Mianserin—HRH2—skin of body—sarcoma	0.00248	0.0149	CbGeAlD
Mianserin—HRH2—cardiac atrium—sarcoma	0.00217	0.013	CbGeAlD
Mianserin—HTR2B—myometrium—sarcoma	0.00198	0.0119	CbGeAlD
Mianserin—SLC6A3—hematopoietic system—sarcoma	0.00187	0.0112	CbGeAlD
Mianserin—HTR2A—endothelium—sarcoma	0.00184	0.0111	CbGeAlD
Mianserin—HTR1D—connective tissue—sarcoma	0.00176	0.0106	CbGeAlD
Mianserin—SLC6A4—hematopoietic system—sarcoma	0.00171	0.0103	CbGeAlD
Mianserin—Agranulocytosis—Dactinomycin—sarcoma	0.00166	0.00669	CcSEcCtD
Mianserin—Pancytopenia—Mitoxantrone—sarcoma	0.00165	0.00664	CcSEcCtD
Mianserin—Erectile dysfunction—Vincristine—sarcoma	0.00164	0.00661	CcSEcCtD
Mianserin—Neutropenia—Mitoxantrone—sarcoma	0.00163	0.00654	CcSEcCtD
Mianserin—Erectile dysfunction—Mitoxantrone—sarcoma	0.0016	0.00644	CcSEcCtD
Mianserin—Hepatitis—Dactinomycin—sarcoma	0.0016	0.00643	CcSEcCtD
Mianserin—Cardiac arrest—Etoposide—sarcoma	0.00159	0.0064	CcSEcCtD
Mianserin—Connective tissue disorder—Thiotepa—sarcoma	0.00158	0.00637	CcSEcCtD
Mianserin—Weight increased—Mitoxantrone—sarcoma	0.00158	0.00636	CcSEcCtD
Mianserin—ADRA2C—myometrium—sarcoma	0.00155	0.00935	CbGeAlD
Mianserin—Drowsiness—Mitoxantrone—sarcoma	0.00155	0.00623	CcSEcCtD
Mianserin—Blood disorder—Epirubicin—sarcoma	0.00155	0.00622	CcSEcCtD
Mianserin—HTR1A—hematopoietic system—sarcoma	0.00152	0.00914	CbGeAlD
Mianserin—Jaundice—Mitoxantrone—sarcoma	0.00151	0.00608	CcSEcCtD
Mianserin—Eye disorder—Thiotepa—sarcoma	0.00151	0.00606	CcSEcCtD
Mianserin—Tinnitus—Thiotepa—sarcoma	0.0015	0.00604	CcSEcCtD
Mianserin—Cardiac disorder—Thiotepa—sarcoma	0.0015	0.00601	CcSEcCtD
Mianserin—HTR2B—smooth muscle tissue—sarcoma	0.00149	0.00898	CbGeAlD
Mianserin—HRH2—liver—sarcoma	0.00148	0.0089	CbGeAlD
Mianserin—HTR2B—skin of body—sarcoma	0.00147	0.00887	CbGeAlD
Mianserin—Angiopathy—Thiotepa—sarcoma	0.00146	0.00588	CcSEcCtD
Mianserin—HTR7—hematopoietic system—sarcoma	0.00145	0.00873	CbGeAlD
Mianserin—Mediastinal disorder—Thiotepa—sarcoma	0.00145	0.00584	CcSEcCtD
Mianserin—Agranulocytosis—Mitoxantrone—sarcoma	0.00145	0.00582	CcSEcCtD
Mianserin—Blood disorder—Doxorubicin—sarcoma	0.00143	0.00576	CcSEcCtD
Mianserin—Bradycardia—Mitoxantrone—sarcoma	0.00142	0.0057	CcSEcCtD
Mianserin—Mental disorder—Thiotepa—sarcoma	0.00141	0.00568	CcSEcCtD
Mianserin—ADRA2C—seminal vesicle—sarcoma	0.0014	0.00845	CbGeAlD
Mianserin—Connective tissue disorder—Vincristine—sarcoma	0.0014	0.00565	CcSEcCtD
Mianserin—HTR7—connective tissue—sarcoma	0.0014	0.00841	CbGeAlD
Mianserin—Hepatitis—Mitoxantrone—sarcoma	0.00139	0.0056	CcSEcCtD
Mianserin—Pancytopenia—Etoposide—sarcoma	0.00137	0.00552	CcSEcCtD
Mianserin—Neutropenia—Etoposide—sarcoma	0.00135	0.00544	CcSEcCtD
Mianserin—Cardiac disorder—Vincristine—sarcoma	0.00133	0.00533	CcSEcCtD
Mianserin—Anaemia—Thiotepa—sarcoma	0.0013	0.00521	CcSEcCtD
Mianserin—Angiopathy—Vincristine—sarcoma	0.0013	0.00521	CcSEcCtD
Mianserin—Agitation—Thiotepa—sarcoma	0.00129	0.00518	CcSEcCtD
Mianserin—Mediastinal disorder—Vincristine—sarcoma	0.00129	0.00518	CcSEcCtD
Mianserin—Anaemia—Dactinomycin—sarcoma	0.00129	0.00517	CcSEcCtD
Mianserin—HTR2B—uterus—sarcoma	0.00128	0.0077	CbGeAlD
Mianserin—HTR7—smooth muscle tissue—sarcoma	0.00128	0.00769	CbGeAlD
Mianserin—HRH1—myometrium—sarcoma	0.00126	0.00759	CbGeAlD
Mianserin—Jaundice—Etoposide—sarcoma	0.00126	0.00505	CcSEcCtD
Mianserin—Leukopenia—Thiotepa—sarcoma	0.00126	0.00505	CcSEcCtD
Mianserin—Mental disorder—Vincristine—sarcoma	0.00125	0.00503	CcSEcCtD
Mianserin—Leukopenia—Dactinomycin—sarcoma	0.00125	0.00501	CcSEcCtD
Mianserin—ADRA2A—myometrium—sarcoma	0.00124	0.00746	CbGeAlD
Mianserin—Hepatobiliary disease—Etoposide—sarcoma	0.00122	0.0049	CcSEcCtD
Mianserin—Convulsion—Thiotepa—sarcoma	0.00122	0.00489	CcSEcCtD
Mianserin—Hypertension—Thiotepa—sarcoma	0.00121	0.00487	CcSEcCtD
Mianserin—Agranulocytosis—Etoposide—sarcoma	0.0012	0.00484	CcSEcCtD
Mianserin—Arthralgia—Thiotepa—sarcoma	0.00119	0.0048	CcSEcCtD
Mianserin—Myalgia—Thiotepa—sarcoma	0.00119	0.0048	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00119	0.00477	CcSEcCtD
Mianserin—Myalgia—Dactinomycin—sarcoma	0.00119	0.00477	CcSEcCtD
Mianserin—CYP1A2—hematopoietic system—sarcoma	0.00116	0.00697	CbGeAlD
Mianserin—Confusional state—Thiotepa—sarcoma	0.00115	0.00464	CcSEcCtD
Mianserin—Anaemia—Vincristine—sarcoma	0.00115	0.00462	CcSEcCtD
Mianserin—Agitation—Vincristine—sarcoma	0.00114	0.0046	CcSEcCtD
Mianserin—Oedema—Dactinomycin—sarcoma	0.00114	0.00457	CcSEcCtD
Mianserin—HRH2—lymph node—sarcoma	0.00113	0.00682	CbGeAlD
Mianserin—Nervous system disorder—Thiotepa—sarcoma	0.00112	0.00451	CcSEcCtD
Mianserin—HTR2B—tendon—sarcoma	0.00112	0.00675	CbGeAlD
Mianserin—Thrombocytopenia—Thiotepa—sarcoma	0.00112	0.00451	CcSEcCtD
Mianserin—ADRA2A—seminal vesicle—sarcoma	0.00112	0.00674	CbGeAlD
Mianserin—Anaemia—Mitoxantrone—sarcoma	0.00112	0.0045	CcSEcCtD
Mianserin—Vertigo—Vincristine—sarcoma	0.00112	0.00449	CcSEcCtD
Mianserin—Tachycardia—Thiotepa—sarcoma	0.00112	0.00449	CcSEcCtD
Mianserin—Leukopenia—Vincristine—sarcoma	0.00111	0.00448	CcSEcCtD
Mianserin—Thrombocytopenia—Dactinomycin—sarcoma	0.00111	0.00447	CcSEcCtD
Mianserin—Skin disorder—Thiotepa—sarcoma	0.00111	0.00447	CcSEcCtD
Mianserin—CYP2B6—hematopoietic system—sarcoma	0.00111	0.00668	CbGeAlD
Mianserin—HRH1—hematopoietic system—sarcoma	0.00108	0.00652	CbGeAlD
Mianserin—Leukopenia—Mitoxantrone—sarcoma	0.00108	0.00436	CcSEcCtD
Mianserin—Eye disorder—Etoposide—sarcoma	0.00108	0.00435	CcSEcCtD
Mianserin—Convulsion—Vincristine—sarcoma	0.00108	0.00433	CcSEcCtD
Mianserin—Cardiac disorder—Etoposide—sarcoma	0.00107	0.00432	CcSEcCtD
Mianserin—Hypertension—Vincristine—sarcoma	0.00107	0.00432	CcSEcCtD
Mianserin—Hepatic function abnormal—Epirubicin—sarcoma	0.00107	0.00432	CcSEcCtD
Mianserin—ADRA2A—hematopoietic system—sarcoma	0.00107	0.00641	CbGeAlD
Mianserin—Myalgia—Vincristine—sarcoma	0.00106	0.00426	CcSEcCtD
Mianserin—Angiopathy—Etoposide—sarcoma	0.00105	0.00422	CcSEcCtD
Mianserin—Convulsion—Mitoxantrone—sarcoma	0.00105	0.00422	CcSEcCtD
Mianserin—Hypertension—Mitoxantrone—sarcoma	0.00105	0.00421	CcSEcCtD
Mianserin—HRH1—connective tissue—sarcoma	0.00104	0.00628	CbGeAlD
Mianserin—Mediastinal disorder—Etoposide—sarcoma	0.00104	0.0042	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00104	0.00419	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00104	0.00416	CcSEcCtD
Mianserin—Arthralgia—Mitoxantrone—sarcoma	0.00103	0.00415	CcSEcCtD
Mianserin—Myalgia—Mitoxantrone—sarcoma	0.00103	0.00415	CcSEcCtD
Mianserin—Paraesthesia—Thiotepa—sarcoma	0.00103	0.00413	CcSEcCtD
Mianserin—ADRA2A—connective tissue—sarcoma	0.00103	0.00617	CbGeAlD
Mianserin—SLC6A3—testis—sarcoma	0.00102	0.00616	CbGeAlD
Mianserin—Somnolence—Thiotepa—sarcoma	0.00102	0.00409	CcSEcCtD
Mianserin—Oedema—Vincristine—sarcoma	0.00102	0.00408	CcSEcCtD
Mianserin—HTR2A—embryo—sarcoma	0.00101	0.0061	CbGeAlD
Mianserin—ADRA2C—cardiac atrium—sarcoma	0.00101	0.0061	CbGeAlD
Mianserin—ADRA2C—uterus—sarcoma	0.00101	0.00606	CbGeAlD
Mianserin—Confusional state—Mitoxantrone—sarcoma	0.000997	0.00401	CcSEcCtD
Mianserin—Nervous system disorder—Vincristine—sarcoma	0.000996	0.004	CcSEcCtD
Mianserin—Thrombocytopenia—Vincristine—sarcoma	0.000994	0.004	CcSEcCtD
Mianserin—Hepatic function abnormal—Doxorubicin—sarcoma	0.000993	0.00399	CcSEcCtD
Mianserin—Oedema—Mitoxantrone—sarcoma	0.000989	0.00398	CcSEcCtD
Mianserin—Gastrointestinal disorder—Thiotepa—sarcoma	0.000988	0.00397	CcSEcCtD
Mianserin—Fatigue—Thiotepa—sarcoma	0.000987	0.00397	CcSEcCtD
Mianserin—Fatigue—Dactinomycin—sarcoma	0.00098	0.00394	CcSEcCtD
Mianserin—Constipation—Thiotepa—sarcoma	0.000979	0.00394	CcSEcCtD
Mianserin—Shock—Mitoxantrone—sarcoma	0.000973	0.00391	CcSEcCtD
Mianserin—Thrombocytopenia—Mitoxantrone—sarcoma	0.000968	0.00389	CcSEcCtD
Mianserin—CYP2B6—skin of body—sarcoma	0.000965	0.00581	CbGeAlD
Mianserin—Tachycardia—Mitoxantrone—sarcoma	0.000965	0.00388	CcSEcCtD
Mianserin—HTR7—tendon—sarcoma	0.000961	0.00578	CbGeAlD
Mianserin—Cardiac failure—Epirubicin—sarcoma	0.000961	0.00386	CcSEcCtD
Mianserin—Skin disorder—Mitoxantrone—sarcoma	0.00096	0.00386	CcSEcCtD
Mianserin—Lethargy—Epirubicin—sarcoma	0.000957	0.00385	CcSEcCtD
Mianserin—HRH1—smooth muscle tissue—sarcoma	0.000955	0.00574	CbGeAlD
Mianserin—Hypotension—Vincristine—sarcoma	0.000949	0.00381	CcSEcCtD
Mianserin—Feeling abnormal—Thiotepa—sarcoma	0.000943	0.00379	CcSEcCtD
Mianserin—Diplopia—Epirubicin—sarcoma	0.000938	0.00377	CcSEcCtD
Mianserin—Feeling abnormal—Dactinomycin—sarcoma	0.000936	0.00377	CcSEcCtD
Mianserin—Anaemia—Etoposide—sarcoma	0.000931	0.00375	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Vincristine—sarcoma	0.000925	0.00372	CcSEcCtD
Mianserin—Hypotension—Mitoxantrone—sarcoma	0.000924	0.00372	CcSEcCtD
Mianserin—Paraesthesia—Vincristine—sarcoma	0.000912	0.00367	CcSEcCtD
Mianserin—HTR2A—hematopoietic system—sarcoma	0.000906	0.00545	CbGeAlD
Mianserin—Vertigo—Etoposide—sarcoma	0.000905	0.00364	CcSEcCtD
Mianserin—Leukopenia—Etoposide—sarcoma	0.000902	0.00363	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000901	0.00362	CcSEcCtD
Mianserin—Cardiac arrest—Epirubicin—sarcoma	0.000892	0.00359	CcSEcCtD
Mianserin—Cardiac failure—Doxorubicin—sarcoma	0.000889	0.00358	CcSEcCtD
Mianserin—Paraesthesia—Mitoxantrone—sarcoma	0.000888	0.00357	CcSEcCtD
Mianserin—Loss of consciousness—Etoposide—sarcoma	0.000886	0.00356	CcSEcCtD
Mianserin—Lethargy—Doxorubicin—sarcoma	0.000886	0.00356	CcSEcCtD
Mianserin—ADRA2C—tendon—sarcoma	0.000883	0.00531	CbGeAlD
Mianserin—Somnolence—Mitoxantrone—sarcoma	0.000879	0.00353	CcSEcCtD
Mianserin—Gastrointestinal disorder—Vincristine—sarcoma	0.000876	0.00352	CcSEcCtD
Mianserin—Fatigue—Vincristine—sarcoma	0.000875	0.00352	CcSEcCtD
Mianserin—Convulsion—Etoposide—sarcoma	0.000873	0.00351	CcSEcCtD
Mianserin—HTR2A—connective tissue—sarcoma	0.000872	0.00524	CbGeAlD
Mianserin—Hypertension—Etoposide—sarcoma	0.00087	0.0035	CcSEcCtD
Mianserin—Constipation—Vincristine—sarcoma	0.000868	0.00349	CcSEcCtD
Mianserin—Diplopia—Doxorubicin—sarcoma	0.000868	0.00349	CcSEcCtD
Mianserin—Fatigue—Mitoxantrone—sarcoma	0.000852	0.00343	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000852	0.00343	CcSEcCtD
Mianserin—Breast disorder—Epirubicin—sarcoma	0.000848	0.00341	CcSEcCtD
Mianserin—Constipation—Mitoxantrone—sarcoma	0.000845	0.0034	CcSEcCtD
Mianserin—CYP3A4—hematopoietic system—sarcoma	0.000838	0.00504	CbGeAlD
Mianserin—Confusional state—Etoposide—sarcoma	0.000829	0.00333	CcSEcCtD
Mianserin—SLC6A2—testis—sarcoma	0.000826	0.00497	CbGeAlD
Mianserin—Cardiac arrest—Doxorubicin—sarcoma	0.000825	0.00332	CcSEcCtD
Mianserin—CYP2D6—hematopoietic system—sarcoma	0.000825	0.00496	CbGeAlD
Mianserin—Asthenia—Thiotepa—sarcoma	0.000821	0.0033	CcSEcCtD
Mianserin—Asthenia—Dactinomycin—sarcoma	0.000815	0.00328	CcSEcCtD
Mianserin—Feeling abnormal—Mitoxantrone—sarcoma	0.000815	0.00328	CcSEcCtD
Mianserin—Pruritus—Thiotepa—sarcoma	0.00081	0.00326	CcSEcCtD
Mianserin—ADRA2A—cardiac atrium—sarcoma	0.000809	0.00486	CbGeAlD
Mianserin—Thrombocytopenia—Etoposide—sarcoma	0.000805	0.00324	CcSEcCtD
Mianserin—ADRA2A—uterus—sarcoma	0.000805	0.00484	CbGeAlD
Mianserin—Tachycardia—Etoposide—sarcoma	0.000803	0.00323	CcSEcCtD
Mianserin—Skin disorder—Etoposide—sarcoma	0.000799	0.00321	CcSEcCtD
Mianserin—HTR2A—smooth muscle tissue—sarcoma	0.000798	0.0048	CbGeAlD
Mianserin—HTR7—testis—sarcoma	0.000796	0.00479	CbGeAlD
Mianserin—Breast disorder—Doxorubicin—sarcoma	0.000784	0.00315	CcSEcCtD
Mianserin—CYP2B6—lymphoid tissue—sarcoma	0.000782	0.0047	CbGeAlD
Mianserin—Pancytopenia—Epirubicin—sarcoma	0.00077	0.0031	CcSEcCtD
Mianserin—Hypotension—Etoposide—sarcoma	0.000768	0.00309	CcSEcCtD
Mianserin—Neutropenia—Epirubicin—sarcoma	0.000758	0.00305	CcSEcCtD
Mianserin—Dizziness—Thiotepa—sarcoma	0.000757	0.00304	CcSEcCtD
Mianserin—DRD2—testis—sarcoma	0.000752	0.00452	CbGeAlD
Mianserin—HTR7—liver—sarcoma	0.000752	0.00452	CbGeAlD
Mianserin—Paraesthesia—Etoposide—sarcoma	0.000738	0.00297	CcSEcCtD
Mianserin—Weight increased—Epirubicin—sarcoma	0.000738	0.00297	CcSEcCtD
Mianserin—ADRA2C—testis—sarcoma	0.000732	0.0044	CbGeAlD
Mianserin—Somnolence—Etoposide—sarcoma	0.000731	0.00294	CcSEcCtD
Mianserin—Asthenia—Vincristine—sarcoma	0.000728	0.00293	CcSEcCtD
Mianserin—Drowsiness—Epirubicin—sarcoma	0.000723	0.00291	CcSEcCtD
Mianserin—Rash—Thiotepa—sarcoma	0.000722	0.0029	CcSEcCtD
Mianserin—Dermatitis—Thiotepa—sarcoma	0.000721	0.0029	CcSEcCtD
Mianserin—HRH1—tendon—sarcoma	0.000718	0.00432	CbGeAlD
Mianserin—Headache—Thiotepa—sarcoma	0.000717	0.00288	CcSEcCtD
Mianserin—Rash—Dactinomycin—sarcoma	0.000716	0.00288	CcSEcCtD
Mianserin—Pancytopenia—Doxorubicin—sarcoma	0.000712	0.00286	CcSEcCtD
Mianserin—Gastrointestinal disorder—Etoposide—sarcoma	0.00071	0.00286	CcSEcCtD
Mianserin—Asthenia—Mitoxantrone—sarcoma	0.000709	0.00285	CcSEcCtD
Mianserin—Fatigue—Etoposide—sarcoma	0.000709	0.00285	CcSEcCtD
Mianserin—ADRA2A—tendon—sarcoma	0.000705	0.00424	CbGeAlD
Mianserin—Jaundice—Epirubicin—sarcoma	0.000704	0.00283	CcSEcCtD
Mianserin—Constipation—Etoposide—sarcoma	0.000703	0.00283	CcSEcCtD
Mianserin—Neutropenia—Doxorubicin—sarcoma	0.000701	0.00282	CcSEcCtD
Mianserin—ADRA2C—liver—sarcoma	0.000692	0.00416	CbGeAlD
Mianserin—Hepatobiliary disease—Epirubicin—sarcoma	0.000684	0.00275	CcSEcCtD
Mianserin—Weight increased—Doxorubicin—sarcoma	0.000683	0.00275	CcSEcCtD
Mianserin—Feeling abnormal—Etoposide—sarcoma	0.000678	0.00273	CcSEcCtD
Mianserin—Agranulocytosis—Epirubicin—sarcoma	0.000674	0.00271	CcSEcCtD
Mianserin—HTR2B—lymph node—sarcoma	0.000674	0.00405	CbGeAlD
Mianserin—Dizziness—Vincristine—sarcoma	0.000671	0.0027	CcSEcCtD
Mianserin—Drowsiness—Doxorubicin—sarcoma	0.000669	0.00269	CcSEcCtD
Mianserin—Bradycardia—Epirubicin—sarcoma	0.00066	0.00266	CcSEcCtD
Mianserin—Jaundice—Doxorubicin—sarcoma	0.000652	0.00262	CcSEcCtD
Mianserin—Hepatitis—Epirubicin—sarcoma	0.000649	0.00261	CcSEcCtD
Mianserin—Rash—Vincristine—sarcoma	0.00064	0.00257	CcSEcCtD
Mianserin—Dermatitis—Vincristine—sarcoma	0.000639	0.00257	CcSEcCtD
Mianserin—Connective tissue disorder—Epirubicin—sarcoma	0.000638	0.00256	CcSEcCtD
Mianserin—Headache—Vincristine—sarcoma	0.000636	0.00256	CcSEcCtD
Mianserin—Hepatobiliary disease—Doxorubicin—sarcoma	0.000632	0.00254	CcSEcCtD
Mianserin—Agranulocytosis—Doxorubicin—sarcoma	0.000624	0.00251	CcSEcCtD
Mianserin—Rash—Mitoxantrone—sarcoma	0.000623	0.00251	CcSEcCtD
Mianserin—Dermatitis—Mitoxantrone—sarcoma	0.000623	0.0025	CcSEcCtD
Mianserin—Headache—Mitoxantrone—sarcoma	0.000619	0.00249	CcSEcCtD
Mianserin—Bradycardia—Doxorubicin—sarcoma	0.000611	0.00246	CcSEcCtD
Mianserin—CYP2B6—testis—sarcoma	0.000608	0.00366	CbGeAlD
Mianserin—Eye disorder—Epirubicin—sarcoma	0.000606	0.00244	CcSEcCtD
Mianserin—Tinnitus—Epirubicin—sarcoma	0.000605	0.00243	CcSEcCtD
Mianserin—Cardiac disorder—Epirubicin—sarcoma	0.000602	0.00242	CcSEcCtD
Mianserin—Hepatitis—Doxorubicin—sarcoma	0.0006	0.00241	CcSEcCtD
Mianserin—CYP1A2—liver—sarcoma	0.0006	0.00361	CbGeAlD
Mianserin—HTR2A—tendon—sarcoma	0.000599	0.0036	CbGeAlD
Mianserin—SLC6A2—lymph node—sarcoma	0.000599	0.0036	CbGeAlD
Mianserin—HRH1—testis—sarcoma	0.000594	0.00357	CbGeAlD
Mianserin—Asthenia—Etoposide—sarcoma	0.00059	0.00237	CcSEcCtD
Mianserin—Connective tissue disorder—Doxorubicin—sarcoma	0.00059	0.00237	CcSEcCtD
Mianserin—Angiopathy—Epirubicin—sarcoma	0.000589	0.00237	CcSEcCtD
Mianserin—Mediastinal disorder—Epirubicin—sarcoma	0.000585	0.00235	CcSEcCtD
Mianserin—ADRA2A—testis—sarcoma	0.000584	0.00351	CbGeAlD
Mianserin—Pruritus—Etoposide—sarcoma	0.000582	0.00234	CcSEcCtD
Mianserin—CYP2B6—liver—sarcoma	0.000575	0.00346	CbGeAlD
Mianserin—Mental disorder—Epirubicin—sarcoma	0.000568	0.00229	CcSEcCtD
Mianserin—Eye disorder—Doxorubicin—sarcoma	0.000561	0.00226	CcSEcCtD
Mianserin—Tinnitus—Doxorubicin—sarcoma	0.00056	0.00225	CcSEcCtD
Mianserin—Cardiac disorder—Doxorubicin—sarcoma	0.000557	0.00224	CcSEcCtD
Mianserin—Angiopathy—Doxorubicin—sarcoma	0.000545	0.00219	CcSEcCtD
Mianserin—Dizziness—Etoposide—sarcoma	0.000544	0.00219	CcSEcCtD
Mianserin—Mediastinal disorder—Doxorubicin—sarcoma	0.000541	0.00218	CcSEcCtD
Mianserin—ADRA2C—lymph node—sarcoma	0.00053	0.00319	CbGeAlD
Mianserin—Mental disorder—Doxorubicin—sarcoma	0.000526	0.00212	CcSEcCtD
Mianserin—Anaemia—Epirubicin—sarcoma	0.000522	0.0021	CcSEcCtD
Mianserin—Agitation—Epirubicin—sarcoma	0.000519	0.00209	CcSEcCtD
Mianserin—Rash—Etoposide—sarcoma	0.000518	0.00209	CcSEcCtD
Mianserin—Dermatitis—Etoposide—sarcoma	0.000518	0.00208	CcSEcCtD
Mianserin—Headache—Etoposide—sarcoma	0.000515	0.00207	CcSEcCtD
Mianserin—Vertigo—Epirubicin—sarcoma	0.000507	0.00204	CcSEcCtD
Mianserin—Syncope—Epirubicin—sarcoma	0.000506	0.00204	CcSEcCtD
Mianserin—Leukopenia—Epirubicin—sarcoma	0.000506	0.00203	CcSEcCtD
Mianserin—Loss of consciousness—Epirubicin—sarcoma	0.000496	0.002	CcSEcCtD
Mianserin—HTR2A—testis—sarcoma	0.000496	0.00298	CbGeAlD
Mianserin—Convulsion—Epirubicin—sarcoma	0.000489	0.00197	CcSEcCtD
Mianserin—Hypertension—Epirubicin—sarcoma	0.000488	0.00196	CcSEcCtD
Mianserin—Anaemia—Doxorubicin—sarcoma	0.000483	0.00194	CcSEcCtD
Mianserin—Myalgia—Epirubicin—sarcoma	0.000481	0.00193	CcSEcCtD
Mianserin—Arthralgia—Epirubicin—sarcoma	0.000481	0.00193	CcSEcCtD
Mianserin—Agitation—Doxorubicin—sarcoma	0.00048	0.00193	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000478	0.00192	CcSEcCtD
Mianserin—Dry mouth—Epirubicin—sarcoma	0.00047	0.00189	CcSEcCtD
Mianserin—Vertigo—Doxorubicin—sarcoma	0.00047	0.00189	CcSEcCtD
Mianserin—HTR2A—liver—sarcoma	0.000469	0.00282	CbGeAlD
Mianserin—Syncope—Doxorubicin—sarcoma	0.000469	0.00188	CcSEcCtD
Mianserin—Leukopenia—Doxorubicin—sarcoma	0.000468	0.00188	CcSEcCtD
Mianserin—Confusional state—Epirubicin—sarcoma	0.000465	0.00187	CcSEcCtD
Mianserin—Oedema—Epirubicin—sarcoma	0.000461	0.00185	CcSEcCtD
Mianserin—Loss of consciousness—Doxorubicin—sarcoma	0.000459	0.00185	CcSEcCtD
Mianserin—Shock—Epirubicin—sarcoma	0.000453	0.00182	CcSEcCtD
Mianserin—Convulsion—Doxorubicin—sarcoma	0.000453	0.00182	CcSEcCtD
Mianserin—CYP2D6—testis—sarcoma	0.000452	0.00272	CbGeAlD
Mianserin—Nervous system disorder—Epirubicin—sarcoma	0.000452	0.00182	CcSEcCtD
Mianserin—Thrombocytopenia—Epirubicin—sarcoma	0.000451	0.00182	CcSEcCtD
Mianserin—Hypertension—Doxorubicin—sarcoma	0.000451	0.00181	CcSEcCtD
Mianserin—Tachycardia—Epirubicin—sarcoma	0.00045	0.00181	CcSEcCtD
Mianserin—Skin disorder—Epirubicin—sarcoma	0.000448	0.0018	CcSEcCtD
Mianserin—Myalgia—Doxorubicin—sarcoma	0.000445	0.00179	CcSEcCtD
Mianserin—Arthralgia—Doxorubicin—sarcoma	0.000445	0.00179	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000442	0.00178	CcSEcCtD
Mianserin—Dry mouth—Doxorubicin—sarcoma	0.000435	0.00175	CcSEcCtD
Mianserin—CYP3A4—liver—sarcoma	0.000434	0.00261	CbGeAlD
Mianserin—HRH1—lymph node—sarcoma	0.000431	0.00259	CbGeAlD
Mianserin—Hypotension—Epirubicin—sarcoma	0.000431	0.00173	CcSEcCtD
Mianserin—Confusional state—Doxorubicin—sarcoma	0.00043	0.00173	CcSEcCtD
Mianserin—CYP2D6—liver—sarcoma	0.000427	0.00257	CbGeAlD
Mianserin—Oedema—Doxorubicin—sarcoma	0.000427	0.00172	CcSEcCtD
Mianserin—ADRA2A—lymph node—sarcoma	0.000423	0.00254	CbGeAlD
Mianserin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00042	0.00169	CcSEcCtD
Mianserin—Shock—Doxorubicin—sarcoma	0.00042	0.00169	CcSEcCtD
Mianserin—Nervous system disorder—Doxorubicin—sarcoma	0.000418	0.00168	CcSEcCtD
Mianserin—Thrombocytopenia—Doxorubicin—sarcoma	0.000418	0.00168	CcSEcCtD
Mianserin—Tachycardia—Doxorubicin—sarcoma	0.000416	0.00167	CcSEcCtD
Mianserin—Skin disorder—Doxorubicin—sarcoma	0.000414	0.00167	CcSEcCtD
Mianserin—Paraesthesia—Epirubicin—sarcoma	0.000414	0.00166	CcSEcCtD
Mianserin—Somnolence—Epirubicin—sarcoma	0.00041	0.00165	CcSEcCtD
Mianserin—Hypotension—Doxorubicin—sarcoma	0.000399	0.0016	CcSEcCtD
Mianserin—Gastrointestinal disorder—Epirubicin—sarcoma	0.000398	0.0016	CcSEcCtD
Mianserin—Fatigue—Epirubicin—sarcoma	0.000397	0.0016	CcSEcCtD
Mianserin—Constipation—Epirubicin—sarcoma	0.000394	0.00159	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000389	0.00156	CcSEcCtD
Mianserin—Paraesthesia—Doxorubicin—sarcoma	0.000383	0.00154	CcSEcCtD
Mianserin—Feeling abnormal—Epirubicin—sarcoma	0.00038	0.00153	CcSEcCtD
Mianserin—Somnolence—Doxorubicin—sarcoma	0.000379	0.00152	CcSEcCtD
Mianserin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000368	0.00148	CcSEcCtD
Mianserin—Fatigue—Doxorubicin—sarcoma	0.000368	0.00148	CcSEcCtD
Mianserin—Constipation—Doxorubicin—sarcoma	0.000365	0.00147	CcSEcCtD
Mianserin—Feeling abnormal—Doxorubicin—sarcoma	0.000351	0.00141	CcSEcCtD
Mianserin—Asthenia—Epirubicin—sarcoma	0.000331	0.00133	CcSEcCtD
Mianserin—Pruritus—Epirubicin—sarcoma	0.000326	0.00131	CcSEcCtD
Mianserin—Asthenia—Doxorubicin—sarcoma	0.000306	0.00123	CcSEcCtD
Mianserin—Dizziness—Epirubicin—sarcoma	0.000305	0.00123	CcSEcCtD
Mianserin—Pruritus—Doxorubicin—sarcoma	0.000302	0.00121	CcSEcCtD
Mianserin—Rash—Epirubicin—sarcoma	0.000291	0.00117	CcSEcCtD
Mianserin—Dermatitis—Epirubicin—sarcoma	0.00029	0.00117	CcSEcCtD
Mianserin—Headache—Epirubicin—sarcoma	0.000289	0.00116	CcSEcCtD
Mianserin—Dizziness—Doxorubicin—sarcoma	0.000282	0.00113	CcSEcCtD
Mianserin—Rash—Doxorubicin—sarcoma	0.000269	0.00108	CcSEcCtD
Mianserin—Dermatitis—Doxorubicin—sarcoma	0.000269	0.00108	CcSEcCtD
Mianserin—Headache—Doxorubicin—sarcoma	0.000267	0.00107	CcSEcCtD
